Milka Linenberg

Title: Milka Linenberg: Innovator in Pharmaceutical Compositions

Introduction

Milka Linenberg is a notable inventor based in Tel-Mond, Israel. He has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment of autoimmune diseases and multiple sclerosis. With a total of 2 patents, Linenberg's work has the potential to impact the lives of many patients.

Latest Patents

Linenberg's latest patents include innovative formulations for oral, nasal, and pulmonary dosage forms of Copolymer 1. These pharmaceutical compositions are designed to treat autoimmune diseases in mammals, utilizing a therapeutically effective amount of Copolymer 1 and microcrystalline cellulose. Additionally, he has developed processes for the manufacture of these compositions. Another significant patent focuses on the treatment of multiple sclerosis through the ingestion or inhalation of Copolymer 1, providing new avenues for effective treatment.

Career Highlights

Milka Linenberg is associated with Yeda Research and Development Co. Ltd., where he has been instrumental in advancing research in pharmaceutical sciences. His work has garnered attention for its innovative approach to treating complex diseases.

Collaborations

Linenberg has collaborated with notable colleagues, including Adrian Gilbert and Ruth Arnon, who is a prominent female scientist in the field. Their combined expertise has contributed to the development of groundbreaking treatments.

Conclusion

Milka Linenberg's contributions to pharmaceutical innovations highlight the importance of research in developing effective treatments for autoimmune diseases and multiple sclerosis. His patents reflect a commitment to improving patient care through scientific advancement.